| 1 |
33586001 | Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders. | 2021 Apr |
2 |
| 2 |
34780049 | 1α,25-(OH)2-D3 promotes the autophagy during osteoclastogenesis by enhancing RANKL-RANK-TRAF6 signaling. | 2021 Oct |
6 |
| 3 |
34948130 | Galectin-3 Contributes to the Inhibitory Effect of lα,25-(OH)2D3 on Osteoclastogenesis. | 2021 Dec 11 |
2 |
| 4 |
30355436 | CCAAT/enhancer-binding protein beta (C/EBPβ) is an important mediator of 1,25 dihydroxyvitamin D3 (1,25D3)-induced receptor activator of nuclear factor kappa-B ligand (RANKL) expression in osteoblasts. | 2019 Jun |
4 |
| 5 |
30850163 | Autophagy exerts pivotal roles in regulatory effects of 1α,25-(OH)2D3 on the osteoclastogenesis. | 2019 Apr 16 |
3 |
| 6 |
29465363 | Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis. | 2018 Sep-Oct |
4 |
| 7 |
24557630 | A significant induction of neutrophilic chemoattractants but not RANKL in synoviocytes stimulated with interleukin 17. | 2015 Jan |
2 |
| 8 |
23824148 | Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. | 2014 Aug |
1 |
| 9 |
23271131 | Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. | 2013 May |
2 |
| 10 |
23339033 | Involvement of geranylgeranylation of Rho and Rac GTPases in adipogenic and RANKL expression, which was inhibited by simvastatin. | 2013 Dec |
2 |
| 11 |
23710436 | 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. | 2013 |
4 |
| 12 |
24348674 | Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. | 2013 |
3 |
| 13 |
21773989 | A new regulator of osteoclastogenesis: estrogen response element-binding protein in bone. | 2011 Oct |
1 |
| 14 |
19131500 | The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. | 2009 Mar |
4 |
| 15 |
19464673 | Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells. | 2009 Jul |
1 |
| 16 |
18202151 | An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3. | 2008 May |
1 |
| 17 |
18555623 | Advances in bone biology and new treatments for bone loss. | 2008 May 20 |
1 |
| 18 |
18932123 | Modifying RANKL/OPG mRNA expression in differentiating and growing human primary osteoblasts. | 2008 Dec |
1 |
| 19 |
19134349 | [Effects of calcitriol on the expression of vitamin D receptor, RANKL and osteoprotegerin in human periodontal ligament cells]. | 2008 Dec |
1 |
| 20 |
17197168 | Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3. | 2007 Mar |
1 |
| 21 |
17352647 | Differential effects of vitamin D analogs on vascular calcification. | 2007 Jun |
1 |
| 22 |
14563699 | Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. | 2004 Feb |
1 |
| 23 |
15389972 | Etiology of Paget's disease and osteoclast abnormalities. | 2004 Nov 1 |
1 |
| 24 |
10693864 | Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. | 2000 Feb |
2 |
| 25 |
10934644 | Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. | 2000 Aug |
2 |
| 26 |
11193242 | Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. | 2000 |
1 |
| 27 |
9794488 | Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. | 1998 Nov |
1 |